PP
DFTX

Pacifica Partners’s Definium Therapeutics DFTX Stock Holding History

Pacifica Partners’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20
Closed -$208 – 555
2024
Q1 		$208 Hold
20
– – ﹤0.01% 501
2023
Q4 		$70 Hold
20
– – ﹤0.01% 546
2023
Q3 		$62 Hold
20
– – ﹤0.01% 537
2023
Q2 		$75 Hold
20
– – ﹤0.01% 476
2023
Q1 		$58 Hold
20
– – ﹤0.01% 487
2022
Q4 		$45 Hold
20
– – ﹤0.01% 464
2022
Q3 		$0 Hold
20
– – ﹤0.01% 493
2022
Q2 		$0 Hold
20
– – ﹤0.01% 502
2022
Q1 		$0 Hold
20
– – ﹤0.01% 492
2021
Q4 		$0 Hold
20
– – ﹤0.01% 506
2021
Q3 		$1K Buy
+20
New +$865 ﹤0.01% 472

Other funds holding DFTX

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pacifica Partners's DFTX Position: Q2 2024 in Review

Pacifica Partners sold out of Definium Therapeutics (DFTX) in Q2 2024, closing a stake of 20 shares — an estimated $208 sold.

Pacifica Partners first reported a position in DFTX in Q3 2021 and held it in 11 quarters. The position peaked at $1K in Q3 2021. 151 funds tracked by Wall St. Rank hold DFTX as of Q2 2024.

  • Pacifica Partners reported no remaining Definium Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Pacifica Partners sold 20 Definium Therapeutics shares in Q2 2024, an estimated $208.
  • Pacifica Partners first reported a position in Definium Therapeutics in Q3 2021 and held it in 11 quarters.
  • Pacifica Partners's Definium Therapeutics position peaked at $1K in Q3 2021.
  • 151 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2024.

Based on Pacifica Partners's 13F filing for Q2 2024, filed 11 Jul 2024.